Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

97.35
Delayed Data
As of 4:02pm ET
 +1.05 / +1.09%
Today’s Change
59.27
Today|||52-Week Range
98.87
+55.46%
Year-to-Date

Today’s Trading

Previous close96.30
Today’s open96.60
Day’s range96.60 - 98.87
Volume6,148,667
Average volume (3 months)6,111,413
Market cap$153.5B
Data as of 4:02pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+15.21%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+12.16%
P/E ratio23.6
Price/Sales3.98
Price/Book33.08

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.04-0.09%
CELGCelgene-0.84-0.77%
BMYBristol-Myers Squibb+0.19+0.30%
GSKGlaxoSmithKline+0.06+0.17%
Data as of 4:01pm ET, 12/13/2017

Financials

Next reporting dateFebruary 2, 2018
EPS forecast (this quarter)$1.44
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts